5-chloro-2-(2-methyl-1-(1H-1,2,3-triazol-1-yl)propyl)-6-(trifluoromethoxy)quinoline | 1381786-80-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 5-chloro-2-(2-methyl-1-(1H-1,2,3-triazol-1-yl)propyl)-6-(trifluoromethoxy)quinoline
• 英文别名: 5-Chloro-2-[2-methyl-1-(triazol-1-yl)propyl]-6-(trifluoromethoxy)quinoline
• CAS: 1381786-80-6
• 化学式: C₁₆H₁₄ClF₃N₄O
• 分子量: 370.762
• InChiKey: DFHIHQGTLHUGNZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  52.8
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• METALLOENZYME INHIBITOR COMPOUNDS
  申请人：Hoekstra William J.

  公开号：US20120149729A1

  公开（公告）日：2012-06-14

  The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

  这项即时发明描述了具有金属酶调节活性的化合物，以及治疗由这些金属酶介导的疾病、疾病或症状的方法。
• PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
  申请人：Cyclacel Limited

  公开号：US20140066436A1

  公开（公告）日：2014-03-06

  The present invention relates to a compound of formula (VII)I, or pharmaceutically acceptable salt or ester thereof, wherein: X is NR 7 ; Y is O or N—(CH 2 ) n R 19 ; n is 1, 2 or 3; m is 1 or 2; R 1 and R 2 are each independently H, alkyl or cycloalkyl; R 4 and R 4′ are each independently H or alkyl; or R 4 and R 4′ together form a spiro cycloalkyl group; R 19 is H, alkyl, aryl or a cycloalkyl group; R 6 is OR 8 or halogen; and R 7 and R 8 are each independently H or alkyl. Further aspects relate to pharmaceutical compositions comprising said compounds and use therefore in the treatment of proliferative disorders and the like.

  本发明涉及一种式（VII）I的化合物，或其药学上可接受的盐或酯，其中：X为NR7；Y为O或N-（CH2）nR19；n为1、2或3；m为1或2；R1和R2各自独立地为H、烷基或环烷基；R4和R4'各自独立地为H或烷基；或R4和R4'共同形成螺环烷基；R19为H、烷基、芳基或环烷基；R6为OR8或卤素；R7和R8各自独立地为H或烷基。此外，本发明还涉及包含所述化合物的制药组合物，并将其用于治疗增殖性疾病等方面。
• US8669274B2
  申请人：——

  公开号：US8669274B2

  公开（公告）日：2014-03-11
• [EN] METALLOENZYME INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE MÉTALLOENZYME
  申请人：VIAMET PHARMACEUTICALS INC

  公开号：WO2012082746A2

  公开（公告）日：2012-06-21

  The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.